Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells

Author：            

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|4|1849-1857

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.4, 2015-01, pp. : 1849-1857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

By                  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-01 ,pp. : 1066-1072

Spandidos Publications

Access to resources Recommend Favorite

Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

By                    

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1049-1057

Spandidos Publications

Access to resources Recommend Favorite

Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells

By          

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 315-324

Spandidos Publications

Access to resources Recommend Favorite

Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells

By            

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1581-1589

Spandidos Publications

Access to resources Recommend Favorite

PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells

By              

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 679-685

Spandidos Publications

Access to resources Recommend Favorite